Similar Stories to Gilead 1q Profit Tumbles On Slower Hepatitis C Drug Sales on Bing News

WASHINGTON (AP) — Gilead Science Inc.'s earnings tumbled 17 percent in first quarter as steeper discounts and rebates on its blockbuster hepatitis C drugs cut into sales.

Topics:  washington ap     gilead science inc   c   sales   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News